US Stock MarketDetailed Quotes

LUMO Lumos Pharma (Delisted)

Watchlist
  • 4.340
  • 0.0000.00%
Close Dec 11 16:00 ET
37.54MMarket Cap-1.01P/E (TTM)

Lumos Pharma (Delisted) Key Stats

Lumos Pharma (Delisted) Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 150.000K--
--2024/Q4-- / 6.933M--
--2024/Q3726.000K / 253.250K--
Aug 1, 20242024/Q2488.000K / 202.600K--
May 15, 20242024/Q1165.000K / 378.250K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 150.000K--
--2024/Q4-- / 6.933M--
--2024/Q3726.000K / 253.250K--
Aug 1, 20242024/Q2488.000K / 202.600K--
May 15, 20242024/Q1165.000K / 378.250K--

Unlock Free Earnings Estimates

Lumos Pharma (Delisted) Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Nov 30, 2024

Buy

  • Buy

    66.67%
  • Hold

    33.33%
  • Sell

    0.00%

Price Target

No Data